Lataa...
Oral fluticasone propionate in active distal ulcerative colitis.
Fluticasone propionate is a new corticosteroid with low systemic bioavailability. This study reports the outcome of a double blind clinical trial comparing oral fluticasone propionate (5 mg four times daily) with placebo for the treatment of active distal ulcerative colitis. Sixty patients were trea...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
1992
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1379308/ https://ncbi.nlm.nih.gov/pubmed/1612492 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|